Baheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each

Stock News

07/21

According to the latest data from the Hong Kong Stock Exchange, on July 16th, Baheal Pharma Group Co., Ltd. increased its stake in BIOSTAR PHARM-B (HKEX: 02563) by 25 million shares. The transaction was executed at a price of HK$4 per share, amounting to a total consideration of HK$100 million.

Following this acquisition, the group's latest shareholding stands at 29.1708 million shares, representing a 7.49% ownership stake.

The transaction involved other related parties, including Baheal Wellness Industry International Trading Limited, Qingdao Baheal Medical Inc., Fu Gang, Beijing Baiyang Huikang Technology Innovation Development Co., Ltd., and Beijing Baiyang Tongxing Management Consulting Co., Ltd.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1104527917"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1104527917\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1104527917?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 19:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104527917","market":"sh","top_or_hot":-1,"title":"Baheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each","media":"Stock News","content":"<p>According to the latest data from the Hong Kong Stock Exchange, on July 16th, <b>Baheal Pharma Group Co., Ltd.</b> increased its stake in <b>BIOSTAR PHARM-B</b> (<b>HKEX: 02563</b>) by 25 million shares. The transaction was executed at a price of HK$4 per share, amounting to a total consideration of HK$100 million.<br><br>Following this acquisition, the group's latest shareholding stands at 29.1708 million shares, representing a 7.49% ownership stake.<br><br>The transaction involved other related parties, including Baheal Wellness Industry International Trading Limited, Qingdao Baheal Medical Inc., Fu Gang, Beijing Baiyang Huikang Technology Innovation Development Co., Ltd., and Beijing Baiyang Tongxing Management Consulting Co., Ltd.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-21 19:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to the latest data from the Hong Kong Stock Exchange, on July 16th, <b>Baheal Pharma Group Co., Ltd.</b> increased its stake in <b>BIOSTAR PHARM-B</b> (<b>HKEX: 02563</b>) by 25 million shares. The transaction was executed at a price of HK$4 per share, amounting to a total consideration of HK$100 million.<br><br>Following this acquisition, the group's latest shareholding stands at 29.1708 million shares, representing a 7.49% ownership stake.<br><br>The transaction involved other related parties, including Baheal Wellness Industry International Trading Limited, Qingdao Baheal Medical Inc., Fu Gang, Beijing Baiyang Huikang Technology Innovation Development Co., Ltd., and Beijing Baiyang Tongxing Management Consulting Co., Ltd.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1104527917","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104527917","pubTimestamp":1784633798,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to the latest data from the Hong Kong Stock Exchange, on July 16th, Baheal Pharma Group Co., Ltd. increased its stake in BIOSTAR PHARM-B (HKEX: 02563) by 25 million shares. The transaction...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1574":"生物医药B类股","BK1515":"抗疫概念","BK1161":"生物科技","09939":"开拓药业-B","EWH":"香港ETF-iShares MSCI","02563":"华昊中天医药-B"},"translate_title":"Baheal Pharma Group以每股4港元收购2500万股BIOSTAR PHARM-B股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"02563":1,"EWH":1},"content_text":"According to the latest data from the Hong Kong Stock Exchange, on July 16th, Baheal Pharma Group Co., Ltd. increased its stake in BIOSTAR PHARM-B (HKEX: 02563) by 25 million shares. The transaction was executed at a price of HK$4 per share, amounting to a total consideration of HK$100 million.Following this acquisition, the group's latest shareholding stands at 29.1708 million shares, representing a 7.49% ownership stake.The transaction involved other related parties, including Baheal Wellness Industry International Trading Limited, Qingdao Baheal Medical Inc., Fu Gang, Beijing Baiyang Huikang Technology Innovation Development Co., Ltd., and Beijing Baiyang Tongxing Management Consulting Co., Ltd.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}